Singleton J Matthew

Singleton J Matthew is listed in filings as Director at Viking Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 5, 2026, including sale activity. Recent filings connect the profile to Viking Therapeutics, Inc. (VKTX). The current snapshot covers public activity from Aug 14, 2024 to Jan 5, 2026. Reported amounts are shown as $722.6K to $1.3M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.